|4Jan 31, 3:56 PM ET

Kalayajian Karen 4

4 · IntelGenx Technologies Corp. · Filed Jan 31, 2024

Insider Transaction Report

Form 4
Period: 2024-01-29
Kalayajian Karen
VP, Finance&Admin - Subsidiary
Transactions
  • Award

    Options (right to buy) p.v.0.00001

    2024-01-29+37,500415,000 total
    Exercise: $0.14From: 2025-01-29Exp: 2034-01-28Common Stock (37,500 underlying)
  • Award

    Options (right to buy) p.v.0.00001

    2024-01-29+37,500371,250 total
    Exercise: $0.14From: 2024-07-29Exp: 2034-01-28Common Stock (37,500 underlying)
  • Award

    Options (right to buy) p.v.0.00001

    2024-01-29+37,500508,750 total
    Exercise: $0.14From: 2026-01-29Exp: 2034-01-28Common Stock (37,500 underlying)
  • Award

    Restricted Share Units (p.v.0.00001 )

    2024-01-29+97,925137,925 total
    Exercise: $0.00From: 2024-01-29Exp: 2029-01-28Common Stock (97,925 underlying)
  • Award

    Options (right to buy) p.v.0.00001

    2024-01-29+37,500465,000 total
    Exercise: $0.14From: 2025-07-29Exp: 2034-01-28Common Stock (37,500 underlying)

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES